Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway

Gemcitabine (GEMZ) is the first-line therapy used against non-small cell lung cancer (NSCLC), and studies have focused on investigating the potential effects of agents combined with GEMZ to enhance the anticancer efficacy in NSCLC. Previous studies have reported that trichosanthin (TCS) has various...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuya, Naren, Wang, Yadi, Tong, Lanmei, Gao, Weishi, Yu, Rong, Xue, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740788/
https://www.ncbi.nlm.nih.gov/pubmed/29285119
http://dx.doi.org/10.3892/etm.2017.5286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740788/
https://www.ncbi.nlm.nih.gov/pubmed/29285119
http://dx.doi.org/10.3892/etm.2017.5286

Ejemplares similares